Tumor volume, density of CD45+ cells, and combined positive score (CPS) defined as the number of programmed cell death ligand 1 (PD-L1)-positive cells (tumor cells, lymphocytes, and macrophages)7 were statistically analyzed before and following therapy. The gene discussed is CD274; the disease is neoplasm.